Magnetar Financial’s Strata Critical Medical SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12,902
Closed -$68K – 1515
2026
Q2
$68K Buy
+12,902
New +$67.9K ﹤0.01% 1092
2021
Q1
– Sell
-1,717,061
Closed -$19M – 1047
2020
Q4
$19M Buy
1,717,061
+1,566,269
+1,039% +$16M 0.27% 79
2020
Q3
$1.52M Hold
150,792
– – 0.03% 293
2020
Q2
$1.5M Buy
150,792
+76,000
+102% +$746K 0.04% 176
2020
Q1
$723K Buy
+74,792
New +$742K 0.02% 231

Other funds holding SRTA

Magnetar Financial's SRTA Position: Q3 2026 in Review

Magnetar Financial sold out of Strata Critical Medical (SRTA) in Q3 2026, closing a stake of 12,902 shares — an estimated $68K sold.

Magnetar Financial first reported a position in SRTA in Q1 2020 and held it in 5 quarters. The position peaked at $19M in Q4 2020. 164 funds tracked by Wall St. Rank hold SRTA as of Q3 2026.

  • Magnetar Financial reported no remaining Strata Critical Medical position as of Q3 2026 after selling out during the quarter.
  • Magnetar Financial sold 12,902 Strata Critical Medical shares in Q3 2026, an estimated $68K.
  • Magnetar Financial first reported a position in Strata Critical Medical in Q1 2020 and held it in 5 quarters.
  • Magnetar Financial's Strata Critical Medical position peaked at $19M in Q4 2020.
  • 164 funds tracked by Wall St. Rank held Strata Critical Medical as of Q3 2026.

Based on Magnetar Financial's 13F filing for Q3 2026, filed 13 Nov 2026.